Literature DB >> 26721358

Ameliorative potential of pioglitazone and ceftriaxone alone and in combination in rat model of neuropathic pain: Targeting PPARγ and GLT-1 pathways.

Raghavender Pottabathini1, Anil Kumar2, Archana Bhatnagar3, Sukant Garg4, E Ekavali1.   

Abstract

BACKGROUND: The relation between glutamate homeostasis and PPAR gamma has got tremendous importance in nerve trauma and pain. Present study has been designed to elucidate the interaction between the GLT-1 activator (ceftriaxone) and PPAR gamma agonist (pioglitazone) in the spinal nerve ligation induced neuropathic pain.
METHODS: Male SD rats were subjected to spinal nerve ligation to induce neuropathic pain. Pioglitazone, ceftriaxone and their combination treatments were given for 28 days. Various behavioral, biochemical, neuroinflammatory and apoptotic mediators were assessed subsequently.
RESULTS: In the present study, ligation of L5 and L6 spinal nerves resulted in marked hyperalgesia and allodynia to different mechanical and thermal stimuli. In addition there is marked increase in oxidative-nitrosative stress parameters, inflammatory and apoptotic markers in spinal cord of spinal nerve ligated rats. Treatment with pioglitazone and ceftriaxone significantly prevented these behavioral, biochemical, mitochondrial and cellular alterations in rats. Further, combination of pioglitazone (10mg/kg, ip) with ceftriaxone (100mg/kg, ip) significantly potentiated the protective effects as compared to their effects per se.
CONCLUSION: Based on these results we propose that possible interplay between the neuroprotective effects of pioglitazone and ceftriaxone exists in suppressing the behavioral, biochemical, mitochondrial, neuroinflammatory and apoptotic cascades in spinal nerve ligation induced neuropathic pain in rats.
Copyright © 2015 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.

Entities:  

Keywords:  GLT-1; Neuropathic pain; PPARgamma; Spinal nerve ligation

Mesh:

Substances:

Year:  2015        PMID: 26721358     DOI: 10.1016/j.pharep.2015.06.010

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  9 in total

1.  Nephroprotective efficacy of ceftriaxone against cisplatin-induced subchronic renal fibrosis in rats.

Authors:  Mohamed M Abdel-Daim; Yasser S El-Sayed; Mabrouk Abd Eldaim; Abdelazim Ibrahim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-12-14       Impact factor: 3.000

Review 2.  PPARs and pain.

Authors:  Bright N Okine; Jessica C Gaspar; David P Finn
Journal:  Br J Pharmacol       Date:  2018-06-03       Impact factor: 8.739

3.  Preconditioning with hydrogen sulfide prevents bone cancer pain in rats through a proliferator-activated receptor gamma/p38/Jun N-terminal kinase pathway.

Authors:  Li Zhuang; Ke Li; Gaowei Wang; Tao Shou; Chunlin Gao; Yong Mao; Mingliang Bao; Mingli Zhao
Journal:  Exp Biol Med (Maywood)       Date:  2017-11-02

Review 4.  Ceftriaxone as a Novel Therapeutic Agent for Hyperglutamatergic States: Bridging the Gap Between Preclinical Results and Clinical Translation.

Authors:  Osama A Abulseoud; Fawaz Alasmari; Abdelaziz M Hussein; Youssef Sari
Journal:  Front Neurosci       Date:  2022-07-05       Impact factor: 5.152

Review 5.  Strategies for Targeted Delivery to the Peripheral Nerve.

Authors:  Kelly A Langert; Eric M Brey
Journal:  Front Neurosci       Date:  2018-11-27       Impact factor: 4.677

6.  p66shc siRNA-Encapsulated PLGA Nanoparticles Ameliorate Neuropathic Pain Following Spinal Nerve Ligation.

Authors:  Nara Shin; Hyo Jung Shin; Yoonyoung Yi; Jaewon Beom; Wonhyung Lee; Choong-Hyun Lee; Dong Woon Kim
Journal:  Polymers (Basel)       Date:  2020-04-29       Impact factor: 4.329

7.  A Comparison of the Antinociceptive Properties of SJP-005 and Morphine in Rats.

Authors:  Joris C Verster; Andrew Scholey; Thomas A Dahl; Jacqueline M Iversen
Journal:  Pharmaceutics       Date:  2021-02-10       Impact factor: 6.321

Review 8.  Drug Repurposing to Target Neuroinflammation and Sensory Neuron-Dependent Pain.

Authors:  Marco Sisignano; Philip Gribbon; Gerd Geisslinger
Journal:  Drugs       Date:  2022-03-07       Impact factor: 9.546

9.  Metformin relieves neuropathic pain after spinal nerve ligation via autophagy flux stimulation.

Authors:  Weidong Weng; Chenglun Yao; Keshav Poonit; Xijie Zhou; Chao Sun; Feng Zhang; Hede Yan
Journal:  J Cell Mol Med       Date:  2018-11-19       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.